Vedicura Pharma Private Limited
About Vedicura Pharma Private Limited
Data last updated:
Vedicura Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 07 June 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC415417.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹18 Lakh. It is led by directors including Tarlochan Singh and Manmeet Singh.
Its last annual general meeting (AGM) was held on 29 November 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 106 DLF Prime Towers Okhla Industrial Area, Okhla Industrial Area Phase – I, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹72,200. For the same year it recorded a net loss of ₹12.69 Lakh and EBITDA of -₹12.69 Lakh.
The company is associated with 1 brand: Vedicura.
Company details
Contact details
Vedicura Pharma Private Limited's registered office is in New Delhi, Delhi.
- Registered Address106 DLF Prime Towers Okhla Industrial Area, Okhla Industrial Area Phase – I, New Delhi, Delhi, India – 110020
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vedicura Pharma operates one associated brand: Vedicura. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Natural supplements and Ayurvedic products for health and wellness in India. | vedicura.in |
Business activity
The main business activity of Vedicura Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Vedicura Pharma Private Limited, buy the company report.
Financials of Vedicura Pharma Private Limited
FY 2024 filings availableVedicura Pharma Private Limited reported revenue of ₹72,200 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹12.69 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹12.69 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Vedicura Pharma Private Limited, buy the company report.
Board of directors of Vedicura Pharma Private Limited
Vedicura Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarlochan Singh Also directs: Simar Scrap Impex Private Limited | Director | 07 Jun 2023 | 3 Years 5 Months | Current |
| Manmeet Singh Also directs: R H International Limited | Director | 07 Jun 2023 | 3 Years 5 Months | Current |
| Sanmeet Singh Also directs: R H International Limited | Director | 07 Jun 2023 | 3 Years 5 Months | Current |
Peer comparison
Vedicura Pharma Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orgagri Private Limited | ₹72,455 (FY 2021) | Hyderabad, Telangana, India | ||||
| Vway Multitech Private Limited | ₹72,377 (FY 2023) | -86.0% | Kota, Rajasthan, India | |||
| Saisiddhi Lifecare Private Limited | ₹72,370 (FY 2024) | -93.0% | Jalna, Maharashtra, India | |||
| Klamod India Private Limited | ₹72,333 (FY 2018) | -14.0% | Amritsar, Punjab, India | |||
| Vedicura Pharma Private Limitedthis company | ₹72,200 (FY 2024) | -₹12.69 Lakh | New Delhi, Delhi, India | |||
| Mart Liner Private Limited | ₹72,090 (FY 2024) | -81.0% | Howrah, West Bengal, India | |||
| Vrindaban Commodeal Private Limited | ₹72,030 (FY 2025) | 4.0% | Howrah, West Bengal, India | |||
| Mulaadhar Lifestyle Private Limited | ₹72,010 (FY 2024) | Bangalore, Karnataka, India | ||||
| SPT Paper & Boards Private Limited | ₹72,000 (FY 2024) | Sivakasi, Tamil Nadu, India | ||||
| Proto Type Electronics Private Limited | ₹72,000 (FY 2024) | Delhi, India |
To see the full peer comparison of Vedicura Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vedicura Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vedicura Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vedicura Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vedicura Pharma Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Manmeet Singh was appointed as Director on 07 Jun 2023.
Frequently asked questions
Vedicura Pharma is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 07 June 2023 (3+ years old) and is registered under CIN U46497DL2023PTC415417.
Vedicura Pharma has 3 current directors:
- Tarlochan Singh - Director
- Manmeet Singh - Director
- Sanmeet Singh - Director
The latest financial statements of Vedicura Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 November 2024. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Vedicura Pharma is U46497DL2023PTC415417. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vedicura Pharma was incorporated on 07 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vedicura Pharma by revenue are Orgagri Private Limited, Vway Multitech Private Limited, Saisiddhi Lifecare Private Limited, Klamod India Private Limited, Mart Liner Private Limited and 4 more, all in the same principal business activity (retail trading).
Manmeet Singh was appointed as Director on 07 Jun 2023. Sanmeet Singh was appointed as Director on 07 Jun 2023. Sarbjeet Singh was appointed as Individual Subscriber on 07 Jun 2023. Vedicura Pharma has 4 board changes on record in total.
The registered office of Vedicura Pharma is at 106 DLF Prime Towers Okhla Industrial Area, Okhla Industrial Area Phase – I, New Delhi, Delhi, India – 110020.
Vedicura Pharma has 1 associated brand: Vedicura.
Vedicura Pharma can be reached at its registered office: 106 DLF Prime Towers Okhla Industrial Area, Okhla Industrial Area Phase – I, New Delhi, Delhi, India – 110020.
Vedicura Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
